A screening blood test originally validated in seriously ill patients without COVID-19 is still clinically useful for ruling out pulmonary embolism in patients hospitalized with the coronavirus, a University...
Using artificial intelligence to analyze the bacteria in a person’s gut microbiome shows promise as a new screening method for cardiovascular disease (CVD), according to preliminary research to...
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok